About Enzymit
Enzymit is a company based in Ness Ziona (Israel) founded in 2020 by Dror Baran.. Enzymit has raised $15 million across 3 funding rounds from investors including Khosla Ventures, Grove Ventures and First Star Ventures. Enzymit offers products and services including Enzyme Design Platform and Cell-free Production Platform. Enzymit operates in a competitive market with competitors including Citrine Informatics, Numat, Molecule.one, Kebotix and Chemical.AI, among others.
- Headquarter Ness Ziona, Israel
- Founders Dror Baran
-
Sectors
Chemicals & Materials
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$15 M (USD)
in 3 rounds
-
Latest Funding Round
$10 M (USD), Series A
Sep 25, 2024
-
Investors
Khosla Ventures
& 4 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Enzymit
Enzymit offers a comprehensive portfolio of products and services, including Enzyme Design Platform and Cell-free Production Platform. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Uses AI for creating efficient novel enzymes.
Enables cheap and localized bioproduction processes.
Unlock access to complete
Unlock access to complete
Funding Insights of Enzymit
Enzymit has successfully raised a total of $15M across 3 strategic funding rounds. The most recent funding activity was a Series A round of $10 million completed in September 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 3
- Last Round Series A — $10.0M
- First Round First Round
- Investors Count 5
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Sep, 2024 | Amount | Series A - Enzymit | Valuation | Grove Ventures | |
| Apr, 2022 | Amount | Seed - Enzymit | Valuation |
investors |
|
| Mar, 2020 | Amount | Grant - Enzymit | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Enzymit
Enzymit has secured backing from 5 investors, including venture fund investors. Prominent investors backing the company include Khosla Ventures, Grove Ventures and First Star Ventures. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Founded Year | Domain | Location | |
|
Early-stage startups are funded by this venture capital firm.
|
Founded Year | Domain | Location | |
|
Investments in technology startups are made by First Star Ventures.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Enzymit
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Enzymit
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Enzymit Comparisons
Competitors of Enzymit
Enzymit operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Citrine Informatics, Numat, Molecule.one, Kebotix and Chemical.AI, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Provider of AI-based solutions for materials informatics
|
|
| domain | founded_year | HQ Location |
Provider of chemical packaging, protection & separation services
|
|
| domain | founded_year | HQ Location |
AI-based software for molecule drug design and synthesis is provided.
|
|
| domain | founded_year | HQ Location |
AI solutions for materials discovery
|
|
| domain | founded_year | HQ Location |
Provider of AI-based chemical synthesis and medicinal analysis platform for researchers
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Enzymit
Frequently Asked Questions about Enzymit
When was Enzymit founded?
Enzymit was founded in 2020.
Where is Enzymit located?
Enzymit is headquartered in Ness Ziona, Israel. It is registered at Ness Ziona, Central District, Israel.
Is Enzymit a funded company?
Enzymit is a funded company, having raised a total of $15M across 3 funding rounds to date.
What does Enzymit do?
Enzymit was founded in 2020 and is based in Ness Ziona, Israel. Operations focus on the biotechnology sector, where computational algorithms are developed to design enzymes. Proprietary tools are utilized for high-throughput enzyme production, and collected data is integrated into deep learning models to enable ongoing optimization of enzyme designs. Services support enzyme engineering for various applications.
Who are the top competitors of Enzymit?
Enzymit's top competitors include Citrine Informatics, Numat and Molecule.one.
What products or services does Enzymit offer?
Enzymit offers Enzyme Design Platform and Cell-free Production Platform.
Who are Enzymit's investors?
Enzymit has 5 investors. Key investors include Khosla Ventures, Grove Ventures, First Star Ventures, Sapir Venture Partners, and MassChallenge.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.